Immix Biopharma Inc
NASDAQ:IMMX

Watchlist Manager
Immix Biopharma Inc Logo
Immix Biopharma Inc
NASDAQ:IMMX
Watchlist
Price: 2.095 USD 2.7% Market Closed
Market Cap: 58.1m USD

Intrinsic Value

IMMX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one IMMX stock under the Base Case scenario is 3.147 USD. Compared to the current market price of 2.095 USD, Immix Biopharma Inc is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMMX Intrinsic Value
3.147 USD
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Immix Biopharma Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
IMMX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for IMMX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Immix Biopharma Inc
NASDAQ:IMMX
US
Biotechnology
Market Cap
57.7m USD
IPO
Dec 16, 2021
US
Biotechnology
Market Cap
57.7m USD
IPO
Dec 16, 2021
Price
$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Immix Biopharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immix Biopharma Inc

Current Assets 20.2m
Cash & Short-Term Investments 17.7m
Receivables 2m
Other Current Assets 541.4k
Non-Current Assets 2.8m
PP&E 2.7m
Other Non-Current Assets 20.5k
Efficiency

Free Cash Flow Analysis
Immix Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immix Biopharma Inc

Revenue
0 USD
Operating Expenses
-22.7m USD
Operating Income
-22.7m USD
Other Expenses
1.1m USD
Net Income
-21.6m USD
Fundamental Scores

IMMX Profitability Score
Profitability Due Diligence

Immix Biopharma Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
Negative Net Income
37/100
Profitability
Score

Immix Biopharma Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

IMMX Solvency Score
Solvency Due Diligence

Immix Biopharma Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

Immix Biopharma Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMMX Price Targets Summary
Immix Biopharma Inc

Wall Street analysts forecast IMMX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMMX is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Lowest
Price Target
7.07 USD
237% Upside
Average
Price Target
7.14 USD
241% Upside
Highest
Price Target
7.35 USD
251% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immix Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IMMX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IMMX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IMMX stock?

The intrinsic value of one IMMX stock under the Base Case scenario is 3.147 USD.

Is IMMX stock undervalued or overvalued?

Compared to the current market price of 2.095 USD, Immix Biopharma Inc is Undervalued by 33%.

Back to Top